Texas Roundup: Adhesys, Emily Keeton, BioMedical Enterprises & Vyopta
Let’s get caught up with the latest innovation news at Xconomy Texas.
—Station Houston co-founder Emily Keeton was the featured speaker at Startup Grind Houston’s most recent fireside chat event. Keeton became the national president of Lemonade Day, an organization that supports entrepreneurship in kids, and spoke specifically about encouraging young women in innovation.
—The University of Texas System is collecting anonymous patient and administrative data from its hospitals around the state to build a data analytics network. The information will be used to analyze and assess improvements to patient care. UT’s board of regents approved $12.4 million to pay for the network.
—Houston’s Adhesys Medical has formed a partnership with a German pharmaceutical company to market its surgical adhesive in Latin America and Europe. Adhesys makes an adhesive “glue” that can be spread on the skin or internally in the body, on organs, in order to seal wounds. The company won the Rice University Business Plan Competition in 2014.
—A San Antonio, TX, maker of nickel-titanium alloy implants has been acquired by a Johnson & Johnson subsidiary. DePuy Synthes purchased BioMedical Enterprises, which makes implants out of Nitinol. DePuy said Nitinol provides “dynamic continuous active compression,” which helps bone healing.
—Vyopta, an Austin company that makes a video conferencing system dashboard for businesses, picked up an additional $1 million in funding. The company had originally announced in February that it has raised $5 million. AVX Partners, Vyopta’s investor in the original round, put up the additional $1 million.